02 November 2023
02 November 2023
In this audio interview, Gonçalo explains how this grant will fund ongoing work on Lesional Obsessive Compulsive Disorder (OCD) that is being developed in collaboration with several members of the Neuropsychiatry Unit. The proposal is to use the results from this work to test a new treatment for OCD through transcranial magnetic stimulation (TMS), which will include the Neuropsychiatry Unit’s first clinical trial using therapeutic TMS.
Listen to the full audio recording to find out more!
26 October 2023
Through the provision of these two-year collaborative research grants, the Chan Zuckerberg Initiative (CZI) programme aims to accelerate cutting-edge research and technology in metabolism and metabolic physiology. The objective of these grants is to map, measure, and integrate metabolism across different scales—from molecules and organelles to cells and tissues—deepening our understanding of human biology, and to investigate the metabolic processes that maintain physiological homeostasis.
04 October 2023
Treatment-resistant depression (TRD) is a particularly challenging form of major depressive disorder. As Albino Oliveira-Maia, head of the Champalimaud Foundation’s Neuropsychiatry Unit and the study’s national coordinator for Portugal, explains, “TRD is defined as the persistence of depressive symptoms despite adequate courses of at least two different antidepressant medications”. Despite repeated therapeutic attempts, these patients’ depressive symptoms remain.
02 October 2023
On October 1st, people in over 150 countries across the globe will celebrate the power of music to unite and contribute towards a more peaceful, joyful, and harmonious society during International Music Day. Here at the Champalimaud Foundation, we have several budding musicians, so we asked one of them to give us some insight into combining music with science.
08 September 2023
“The brain’s primary function is movement”, explains Claudia Feierstein, lead author of the study published today in Current Biology. “Plants don’t need a brain because they don’t move. Yet, even for something as seemingly simple as eye movements, the brain’s role remains largely enigmatic. Our goal is to illuminate this ‘black box’ of motion and to decode how neural activity controls eye and body movements, using zebrafish as our model organism”.
28 Jul. 2023
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Junior Digital Pathology Scientist to join our Histopathology Platform team, at the Champalimaud Research Programme.
Work closely with senior experimental pathologists and laboratory staff to support a variety of research projects, in the field of digital pathology. Responsibilities will include:
13 July 2023
From Aristotle’s musings on the nature of time to Einstein’s theory of relativity, humanity has long pondered: how do we perceive and understand time? The theory of relativity posits that time can stretch and contract, a phenomenon known as time dilation. Just as the cosmos warps time, our neural circuits can stretch and compress our subjective experience of time. As Einstein famously quipped, “Put your hand on a hot stove for a minute, and it seems like an hour. Sit with a pretty girl for an hour, and it seems like a minute”.
15 June 2023
The exploration of alternative therapeutics for hard-to-treat mental health disorders has brought into focus an array of psychedelics such as psilocybin, present in ‘magic mushrooms’, and LSD, substances once associated more with counterculture than clinical practice. Alongside ‘atypical’ psychedelics like ketamine and MDMA, these substances are increasingly being recognised for their potential therapeutic attributes.